214 related articles for article (PubMed ID: 31873861)
1. Long-term methicillin-resistant Staphylococcus aureus bacteremia persisting for more than 2 weeks: risk factors and outcomes.
Lee YM; Chong YP; Kim M; Eom Y; Kim ES; Kim M; Park KH; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):773-781. PubMed ID: 31873861
[TBL] [Abstract][Full Text] [Related]
2. Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates.
Chong YP; Park SJ; Kim HS; Kim ES; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Medicine (Baltimore); 2013 Mar; 92(2):98-108. PubMed ID: 23429353
[TBL] [Abstract][Full Text] [Related]
3. Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.
Ok HS; Lee HS; Park MJ; Kim KH; Kim BK; Wi YM; Kim JM
Korean J Intern Med; 2013 Nov; 28(6):678-86. PubMed ID: 24307843
[TBL] [Abstract][Full Text] [Related]
4. agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Kang CK; Kim YK; Jung SI; Park WB; Song KH; Park KH; Choe PG; Jang HC; Lee S; Kim YS; Kwak YG; Kwon KT; Kiem S; Kim CJ; Kim ES; Kim HB;
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2187-2191. PubMed ID: 28639163
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
6. Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.
Guillamet MCV; Vazquez R; Deaton B; Shroba J; Vazquez L; Mercier RC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203479
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome.
Kim T; Kim ES; Park SY; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Chong YP; Kim YS
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1473-1481. PubMed ID: 28337607
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein predicts persistent bacteremia caused by community-acquired methicillin-resistant Staphylococcus aureus strain.
Chung H; Kim E; Yang E; Lee YW; Park JH; Bae S; Jung J; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2497-2504. PubMed ID: 34245388
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
[TBL] [Abstract][Full Text] [Related]
10. Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.
Kuint J; Barzilai A; Regev-Yochay G; Rubinstein E; Keller N; Maayan-Metzger A
Eur J Pediatr; 2007 Apr; 166(4):319-25. PubMed ID: 17051356
[TBL] [Abstract][Full Text] [Related]
11. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
[TBL] [Abstract][Full Text] [Related]
12. Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia.
Kim T; Chong YP; Park KH; Bang KM; Park SJ; Kim SH; Jeong JY; Lee SO; Choi SH; Woo JH; Kim YS
Korean J Intern Med; 2019 Jan; 34(1):184-194. PubMed ID: 28859468
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of bacteremia caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital.
Yamada K; Yanagihara K; Hara Y; Araki N; Harada Y; Morinaga Y; Matsuda J; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Kohno S; Kamihira S
Tohoku J Exp Med; 2011 May; 224(1):61-7. PubMed ID: 21551983
[TBL] [Abstract][Full Text] [Related]
14. Decreased Incidence of Methicillin-Resistant Staphylococcus aureus Bacteremia in Intensive Care Units: a 10-Year Clinical, Microbiological, and Genotypic Analysis in a Tertiary Hospital.
Kim H; Kim ES; Lee SC; Yang E; Kim HS; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32747360
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
[TBL] [Abstract][Full Text] [Related]
16. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Molecular Characteristics of
Hong SI; Lee YM; Park KH; Ryu BH; Hong KW; Kim S; Bae IG; Cho OH
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718251
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.
Cuervo G; Camoez M; Shaw E; Dominguez MÁ; Gasch O; Padilla B; Pintado V; Almirante B; Molina J; López-Medrano F; Ruiz de Gopegui E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MÁ; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
BMC Infect Dis; 2015 Oct; 15():484. PubMed ID: 26518487
[TBL] [Abstract][Full Text] [Related]
19. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
Ho KM; Robinson JO
Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
